Growth Metrics

Elevance Health (ELV) Return on Invested Capital (2016 - 2025)

Elevance Health (ELV) has disclosed Return on Invested Capital for 17 consecutive years, with 0.0% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Invested Capital fell 11.0% to 0.0% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.0%, a 11.0% decrease, with the full-year FY2024 number at 0.02%, changed 0.0% from a year prior.
  • Return on Invested Capital was 0.0% for Q3 2025 at Elevance Health, up from 1.44% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.49% in Q2 2024 to a low of 1.74% in Q3 2022.
  • A 5-year average of 0.65% and a median of 0.67% in 2023 define the central range for Return on Invested Capital.
  • Peak YoY movement for Return on Invested Capital: soared 160bps in 2024, then plummeted -194bps in 2025.
  • Elevance Health's Return on Invested Capital stood at 1.45% in 2021, then skyrocketed by 49bps to 0.74% in 2022, then skyrocketed by 73bps to 0.2% in 2023, then tumbled by -78bps to 0.35% in 2024, then soared by 99bps to 0.0% in 2025.
  • Per Business Quant, the three most recent readings for ELV's Return on Invested Capital are 0.0% (Q3 2025), 1.44% (Q2 2025), and 0.24% (Q1 2025).